Posts

Research & Innovation Campus building entrance

Children’s National Research & Innovation Campus welcomes new resident company, AlgometRx

Research & Innovation Campus building entrance

Located on a nearly 12-acre portion of the former Walter Reed Army Medical Center campus, the Children’s National Research & Innovation Campus is the nation’s first campus dedicated to pediatrics, which formally opens in September 2021.

On April 26, 2021, AlgometRx Inc., a Children’s National spinout company developing a handheld device to objectively measure pain by pupillary response, will relocate to Johnson & Johnson Innovation – JLABS @ Washington, DC on the Children’s National Research & Innovation Campus. The AlgometRx move comes following the company being awarded the JLABS @ Washington, DC Children’s QuickFire Challenge, which includes a one-year residency at the newly opened JLABS @ Washington, DC – a 32,000-square-foot incubator located at the new Children’s National Research & Innovation Campus in northwest Washington, D.C. As an awardee, AlgometRx also receives access to research and development space, capital equipment, mentorship, resources and programming.

Located on a nearly 12-acre portion of the former Walter Reed Army Medical Center campus, the Children’s National Research & Innovation Campus is the nation’s first campus dedicated to pediatrics, which formally opens in September 2021. This campus aims to help address a significant problem: the development of medical and surgical devices for children has long lagged behind that for adults. Over the past decade, only one in four medical devices approved by the Food and Drug Administration (FDA) were indicated for use in children, and the majority were for those ages 12 and up.

By bringing together public and private partners, the campus is a one-of-a-kind innovation ecosystem that aims to accelerate breakthrough discoveries into new treatments and technologies.

AlgometRx was founded by pediatric anesthesiologist Julia C. Finkel, M.D., and originated at the Sheikh Zayed Institute for Pediatric Surgical Innovation at Children’s National.

“Pain is the only vital sign that is not objectively measured,” Finkel said. “The current standard of measuring pain is the 0-10 scale, which is based on observations and subjective assessment. This technique increases the likelihood for inaccuracies, especially for infants and children who cannot clearly communicate their pain.”

Finkel’s research was inspired by a desire to find an objective measurement of pain in nonverbal pediatric patients so physicians can better determine the appropriate pain treatment or the effectiveness of a treatment.

“The Children’s National Research & Innovation Campus enables AlgometRx to focus almost exclusively on collecting data, which is the most crucial step at this time,” Finkel said.

AlgometRx aims to submit a formal application to the FDA in the next 12-18 months, with the next six months dedicated to validating the device through a clinical trial.

“The campus also allows us to take advantage of a vast network of the nation’s most innovative pediatric researchers who can provide mentorship on subjects like clinical trial design, prototyping and grant applications,” Finkel said. “Just outside the campus, our team has proximity to relevant federal agencies, such as the FDA, meaning that to date, we’ve only met with FDA officials in person. This advantageous environment will accelerate our progress and allow us to use this technology to more quickly benefit children in pain.”

After its September grand opening, the Children’s National Research & Innovation Campus aims to expand its role as a biomedical incubator to include about 50 start-up companies, working to translate potential breakthrough discoveries into new treatments and technologies.

Learn more at www.childrensnational.org/innovationinstitute.

Research & Innovation Campus building entrance

Research campus provides opportunities for entrepreneurs and innovators

Research & Innovation Campus building entrance

Artist’s rendering of the entrance to the research building on the Children’s National Research & Innovation Campus.

In 2021, Children’s National Hospital intends to open a one-of-a-kind pediatric research and innovation hub, located on a portion of the former Walter Reed Army Medical Center campus. Called the Children’s National Research & Innovation Campus, this collection of facilities will house both our Research and Rare Disease Institutes. In the 160,000 square foot space, we are excited to pursue breakthrough potential discoveries that aim to quickly translate into new treatments and technologies benefitting our most vulnerable population, children and babies.

The campus also represents an opportunity for entrepreneurs and innovators who share our passion for finding new and better ways to care for children thanks to a collaboration with Johnson & Johnson Innovation called JLABS @ Washington, DC, a facility within the campus.

Strategically located with proximity to leading academic research institutions, medical schools and federal research institutions and agencies, the JLABS @ Washington, DC site will be open to emerging pharmaceutical, medical device, consumer and health technology companies aiming to advance the development of new drugs, medical devices, precision diagnostics and health technologies, including applications in pediatrics.

Johnson & Johnson Innovation – JLABS, in addition to offering emerging life science companies modular lab units, office space, shared core laboratory equipment and business facilities, aims to link the entrepreneurs within the District and across the greater Virginia and Maryland regions with the full breadth of the Johnson & Johnson Innovation model, including opportunities for collaboration, a resource hub, educational events and mentorship from experts from the Johnson & Johnson Family of Companies. AlgometRx, a spin-off company from Children’s National Hospital, will be among the first residents of JLABS @ Washington, DC, which aims to opens in 2021, as an awardee of the JLABS @ Washington, DC Children’s QuickFire Challenge.

AlgometRx’s novel technology was developed by hospital pain medicine expert Julia Finkel, M.D., The non-invasive handheld device aims to objectively measure pain by capturing real-time images of a patient’s pupillary response and applies proprietary algorithms to determine the patient’s pain type and intensity.

Do you have a pharmaceutical, medical device, consumer health or health technology innovation that could benefit from this unique and transformational ecosystem? If so, we invite you to submit an application to be considered for joining us at JLABS @ Washington, DC. Learn more by visiting the JLABS website.